952059-64-2

Basic information

• Product Name: 6-METHOXY-1H-1,7-NAPHTHYRIDIN-4-ONE
• Synonyms: 6-METHOXY-1H-1,7-NAPHTHYRIDIN-4-ONE;6-methoxy-1,7-naphthyridin-4(1H)-one
• CAS NO: 952059-64-2
• Molecular Formula: C9H8N2O2
• Molecular Weight: 176.17
• Mol File: 952059-64-2.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 6-METHOXY-1H-1,7-NAPHTHYRIDIN-4-ONE(CAS DataBase Reference)
• NIST Chemistry Reference: 6-METHOXY-1H-1,7-NAPHTHYRIDIN-4-ONE(952059-64-2)
• EPA Substance Registry System: 6-METHOXY-1H-1,7-NAPHTHYRIDIN-4-ONE(952059-64-2)

Safety Data

• Hazardous Substances Data: 952059-64-2(Hazardous Substances Data)

Upstream product

• 34392-85-3 3-amino-2-chloro-6-methoxypyridine 
• 952059-62-0 5-[[(2-chloro-6-methoxypyridin-3-yl)amino]methylidene]-2,2-dimethyl-1,3-dioxane-4,6-dione 
• 38533-61-8 2-chloro-6-methoxy-3-nitropyridine 
• 1018812-95-7 tert-butyl N-(4-acetyl-6-methoxypyridin-3-yl)carbamate 
• 183741-80-2 tert-butyl N-(6-methoxypyridin-3-yl)carbamate 
• 6628-77-9 6-methoxy-pyridin-3-ylamine 
• 952059-63-1 8-chloro-6-methoxy-1H-1,7-naphthyridin-4-one 

Downstream Products

• 952059-61-9 4-chloro-6-methoxy-1,7-naphthyridine 
• 1431985-23-7 C₂₃H₂₄F₂N₆O₂ 
• 1431985-54-4 6-methoxy-1,7-naphthyridin-4(1H)-one 
• 1431985-53-3 6-methoxy-1,7-naphthyridin-4(1H)-one 

Relevant articles and documents

Discovery of a novel series of thienopyrimidine as highly potent and selective PI3K inhibitors

Inhibition of the phosphoinositide 3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) signaling pathway provides a promising new approach for cancer therapy. Through a rational design, a novel series of thienopyrimidine was discovered as highly pote

NAPHTHYRIDINE DERIVATIVES

The invention concerns naphthyridine derivatives of Formula (Ia) or (Ib) or a pharmaceutically-acceptable salt thereof, wherein each of X1, p, R1, G1, G2, q, R2, R3, R4, R5, Ring A, r and R6 has any of the meanings defined hereinbefore in the description; pharmaceutical compositions containing them and their use in the treatment of cell proliferative disorders or disease states associated with angiogenesis and/or vascular permeability.